-
Mashup Score: 0At 3 Years IOP Controlled in More Subjects With Travoprost Implant vs Topical Timolol - 1 hour(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: www.glaucomaphysician.netCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1Right Ventricular Myocardial Infarction—A Tale of Two Ventricles: JACC Focus Seminar 1/5 - 1 hour(s) ago
AbstractRight ventricular infarction (RVI) complicates 50% of cases of acute inferior ST-segment elevation myocardial infarction, and is associated with high in-hospital morbidity and mortality. Is…
Source: www.jacc.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Eye Health Equity | ADA - 1 hour(s) ago
Through this initiative, the ADA and Genentech are working alongside community partners to identify and remove barriers to eye care and drive change in local communities and health systems.
Source: diabetes.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Dropbox users beware - 1 hour(s) ago
Join thousands of subscribers keeping safe with our 3 min daily newsletter that informs you of all the current hacks, scams, phishing attacks and crypto cons, don’t fall for any bull keep your data safe.
Source: gonephishing.beehiiv.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Dr. Williams' Story | Vernon B. Williams, MD, Inc. - 1 hour(s) ago
Dr. Williams’ Story – Work with an expert Los Angeles sports neurologist today! Vernon B. Williams, MD is Board Certified and is ready to help you. Call today for more information.
Source: www.vernonwilliamsmd.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Preoperative single-dose camrelizumab and/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial - 1 hour(s) ago
Innovative treatments are still needed to reduce metastatic disease for early-stage breast cancer. Pan et al. found that local microwave ablation combined with camrelizumab showed a favorable local effect and systemic immune response in the treatment of early-stage breast cancer, and the long-term effect of this strategy is worth investigating.
Source: www.cell.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity After Supportive Stem Cell Boost in Multiple Myeloma - PubMed - 1 hour(s) ago
Bispecific antibodies have meaningfully expanded the therapeutic armentarium in multiple myeloma. Talquetamab is a CD3+ T cell redirecting antibody targeting GPRC5D, which is expressed on multiple myeloma plasma cells as well as in keratinized tissues. Due to the expression pattern, toxicity of talq …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Experts are hopeful that objective biomarker measures for amyotrophic lateral sclerosis, such as the ones being developed by EverythingALS, will lead to more targeted, effective treatments.
Source: www.biospace.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 4Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing - 1 hour(s) ago
Nature Communications – Genomic surveillance of Plasmodium falciparum could improve monitoring of drug resistance, but implementation has been hampered due to the large and complex genome. Here, de…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study - 1 hour(s) ago
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Categories: General Medicine News, Onc News and JournalsTweet
The iDose TR slow-eluting travoprost intraocular implant (Glaukos) controlled IOP in more subjects than timolol 0.5% at 3 years, according to data presented at AAO. https://t.co/4pSCUAuVGe https://t.co/UdgrHvySGN